Point Mutation

A point mutation is a heritable alteration affecting a single nucleotide base pair (1 bp) within a DNA or RNA molecule. Representing the most elementary unit of genetic mutation, point mutations encompass single-nucleotide base substitutions—in which one canonical Watson–Crick base pair (A:T or G:C) is replaced by another—as well as single-base insertions or deletions (1-bp indels), which shift the translational reading frame of protein-coding exons to cause a frameshift mutation. In human germline pedigrees analyzed by whole-genome DNA sequencing, spontaneous single-nucleotide substitutions arise at an average rate of approximately 1.2 × 10⁻⁸ per base pair per generation (yielding ~60 to 80 de novo single-nucleotide variants per newborn), driven by replicative polymerase misincorporation, spontaneous hydrolytic deamination of methylated cytosine (5mC → T), and oxidative base damage that escapes DNA repair. Depending on whether a substitution falls within intergenic DNA, cis-regulatory enhancers, splice junctions, or open reading frames of codons, its phenotypic impact spans from selectively neutral polymorphism to loss or gain of protein function.

Purine/Pyrimidine Substitutions and the Ti/Tv Ratio

Single-nucleotide base substitutions are classified structurally according to the heterocyclic ring chemistry of the exchanged nitrogenous bases—bicyclic purines (adenine A and guanine G) versus monocyclic pyrimidines (cytosine C and thymine T, or uracil U in RNA):

1. Transitions (Ti): Replacement of a purine by the other purine (A ↔ G) or a pyrimidine by the other pyrimidine (C ↔ T). Out of the twelve possible directional single-base changes, four are transitions (A→G, G→A, C→T, T→C), which preserve the purine–pyrimidine orientation of the two DNA strands.
2. Transversions (Tv): Replacement of a purine by a pyrimidine, or a pyrimidine by a purine (A/G ↔ C/T). Out of the twelve directional base substitutions, eight are transversions (A→C, A→T, G→C, G→T, C→A, C→G, T→A, T→G).

`` Purines (Bicyclic) Pyrimidines (Monocyclic) ┌───────────────────┐ ┌───────────────────┐ │ Adenine (A) │ ◄──────► │ Cytosine (C) │ │ ▲ │ Trans- │ ▲ │ │ │ Ti │ versions │ │ Ti │ │ ▼ │ (Tv) │ ▼ │ │ Guanine (G) │ ◄──────► │ Thymine (T) │ └───────────────────┘ └───────────────────┘ Transitions (Ti, 4 pathways): A ↔ G and C ↔ T Transversions (Tv, 8 pathways): {A, G} ↔ {C, T} ``

If all twelve base substitutions occurred at equal random probabilities, the ratio of transitions to transversions (Ti/Tv ratio, κ) would be 4 / 8 = 0.50. In empirical vertebrate genomes, however, transitions outnumber transversions by roughly 4-fold per pathway, yielding an observed genome-wide Ti/Tv ratio of ~2.0 to 2.1, and ~3.0 inside protein-coding exons. Three biochemical factors explain this transition bias:

• Steric geometry in the polymerase active site: Purine–pyrimidine wobble mispairs (G•T or A•C) have a C1′–C1′ glycosidic distance (~10.5 Å) close to Watson–Crick pairs, escaping steric exclusion by DNA polymerases more readily than bulky purine–purine (A•G) or narrow pyrimidine–pyrimidine (C•T) mispairs.
• Hypermutability of methylated CpG dinucleotides (C→T): In vertebrate genomes, 70–80% of cytosines within 5′-CpG-3′ dinucleotides are methylated at carbon-5 (5-methylcytosine, 5mC). Whereas spontaneous deamination of unmethylated cytosine yields uracil (U)—which is excised by uracil-DNA glycosylase (UNG)—spontaneous deamination of 5-methylcytosine yields canonical thymine (T), creating a T:G mismatch. If replication occurs before thymine-DNA glycosylase (TDG) repairs the lesion, one daughter duplex fixes a C:G → T:A transition, elevating the mutation rate at methylated CpG sites by 10- to 50-fold above the genomic average.
• Purifying selection at degenerate third-codon positions: Because third-base wobble positions in the genetic code are 2-fold degenerate for transitions (U/C or A/G), synonymous transitions survive purifying selection in exons more often than non-synonymous transversions.

Single-Base Insertions and Deletions (+1 / −1 Frameshifts)

The term point mutation also includes the insertion (+1 bp) or deletion (−1 bp) of a single nucleotide pair, typically generated by Streisinger replication slippage across homopolymer runs (AAAAAAA). When a +1 or −1 indel occurs within a protein-coding exon, because the ribosome translates codons in non-overlapping triplets (3 nt), every downstream codon is shifted out of phase—causing a frameshift mutation that alters the downstream amino acid sequence and encounters an out-of-frame premature termination codon (UAA, UAG, or UGA).

Synonymous, Missense (Glu6Val), Nonsense, and Splice-Site Classes

Because 61 sense codons specify 20 standard amino acids via third-position wobble base pairing, a substitution that converts one codon into a synonym encoding the same amino acid (CUU → CUC, leucine) is a synonymous (silent) mutation—though synonymous changes can still disrupt exonic splicing enhancers (ESEs) (as in SMN2 exon 7 c.840C>T in spinal muscular atrophy) or co-translational folding kinetics.

A substitution that specifies a different amino acid is a missense (non-synonymous) mutation. While conservative missense changes swap chemically similar side chains (Val ↔ Ile), non-conservative missense changes alter charge, polarity, or backbone geometry. In sickle cell disease, a single A-to-T transversion at codon 6 of the β-globin gene (HBB c.20A>T, converting GAG → GTG on the coding strand and GUG in mRNA) replaces negatively charged hydrophilic glutamic acid (Glu) with neutral hydrophobic valine (Val, Glu6Val), creating a surface patch that polymerizes deoxygenated hemoglobin S into rigid fibers. Conversely, oncogenic missense mutations confer constitutive gain of function, such as BRAF Val600Glu or KRAS Gly12Asp.

A nonsense mutation converts a sense triplet into a termination codon (UAA, UAG, or UGA). Transcripts carrying a premature termination codon (PTC) located >50–55 nucleotides upstream of the final exon–exon junction are degraded by Nonsense-Mediated mRNA Decay (NMD) via the Exon Junction Complex (EJC) and UPF1–3 surveillance proteins. At intron boundaries, point mutations in the invariant 5′-GT donor or 3′-AG acceptor dinucleotides abolish normal splicing.

Tautomeric Errors, 8-Oxoguanine, and Luria–Delbrück Fluctuation Analysis

Point mutations arise from two primary molecular sources:

1. Tautomeric Replication Errors: Canonical bases transiently shift from predominant keto (G, T) or amino (A, C) states into rare enol (G*, T*) or imino (A*, C*) tautomers during DNA replication, allowing T* to pair with G and C* to pair with A. Replicative base selection (~10⁻⁵), 3′ → 5′ exonuclease proofreading (~10⁻⁷), and post-replicative Mismatch Repair (MMR, MutSα/MutLα) lower net error rates to ~10⁻¹⁰ per base replicated.
2. Oxidative and Exogenous Lesions: Reactive oxygen species oxidize guanine to 8-oxoguanine (8-oxoG), which rotates into the syn conformation and Hoogsteen-pairs with adenine (A); unless repaired by OGG1 and MUTYH, replication produces a G:C → T:A transversion. Similarly, UV pyrimidine dimers drive C → T transitions, and tobacco benzo[a]pyrene adducts drive G:C → T:A transversions.

In 1943, Salvador Luria and Max Delbrück used bacteriophage T1 resistance in Escherichia coli (fluctuation test) to prove that point mutations do not arise in response to selection; across parallel cultures, mutant counts followed the non-Poisson Luria–Delbrück jackpot distribution (Variance ≫ Mean), demonstrating that mutations arise spontaneously prior to selection.

Why are C → T transitions at CpG sites the single most common point mutation in humans?

In mammalian genomes, DNA methyltransferases attach a methyl group to the C5 atom of cytosine in 5′-CpG-3′ dinucleotides, producing 5-methylcytosine (5mC). Both unmethylated cytosine and 5mC undergo spontaneous hydrolytic deamination in water at 37 °C. However, deamination of unmethylated cytosine produces uracil (U), which is recognized as foreign to DNA and excised by uracil-DNA glycosylase. In contrast, deamination of 5mC produces thymine (T)—a canonical DNA base—resulting in a T:G mismatch that is repaired less efficiently, leaving C:G → T:A transitions and depleting CpG dinucleotides across vertebrate genomes.

What is the difference between a somatic point mutation, a germline de novo mutation, and a SNP?

The distinction depends on which cell lineage acquires the mutation and how common it is in the population. A somatic point mutation arises in a non-reproductive body cell (such as a skin melanocyte or lung cell); it can drive clonal expansion or cancer in that individual, but it is not transmitted to offspring. A de novo germline mutation arises in a parental germ cell (sperm or egg, with ~75–80% originating on the paternal chromosome in correlation with paternal age) and is inherited by every cell of the child. Once a germline variant reaches a population minor allele frequency of at least 1% (MAF ≥ 0.01), it is classified as a Single-Nucleotide Polymorphism (SNP).

How can nonsense-mediated decay (NMD) make two nonsense mutations in the same gene cause different clinical outcomes?

The position of a nonsense mutation relative to the final exon–exon junction determines whether the mutant mRNA is destroyed or translated. If a nonsense point mutation falls in an early or middle exon (>50–55 nucleotides upstream of the last splice junction), the NMD surveillance machinery degrades the mRNA before protein accumulates, causing haploinsufficiency (50% normal protein from the wild-type allele, which is often asymptomatic in recessive carriers). Conversely, if a nonsense mutation falls in the final exon, no downstream Exon Junction Complex remains to trigger NMD; the cell translates a stable, C-terminally truncated protein that can poison wild-type complexes via a dominant-negative mechanism.

1. Luria, S. E., & Delbrück, M. "Mutations of bacteria from virus sensitivity to virus resistance." Genetics 28, 491–511 (1943). https://doi.org/10.1093/genetics/28.6.491
2. Ingram, V. M. "Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin." Nature 180, 326–328 (1957). https://doi.org/10.1038/180326a0
3. Coulondre, C., Miller, J. H., Farabaugh, P. J., & Gilbert, W. "Molecular basis of base substitution hotspots in Escherichia coli." Nature 274, 775–780 (1978). https://doi.org/10.1038/274775a0
4. Alexandrov, L. B., et al. "Signatures of mutational processes in human cancer." Nature 500, 415–421 (2013). https://doi.org/10.1038/nature12477